Gueimonde M, Ruas-Madiedo P, Margolles A. Bifidobacterium longum subsp. infantis CECT7210

(B. infantis IM-1®) Displays In Vitro Activity against Some Intestinal Pathogens. Nutrients. 2020;

12(11):3259.

2. Wickens K, Barthow C, Mitchell EA, Kang J, van Zyl N, Purdie G, Stanley T, Fitzharris P, Murphy R,

Crane J. Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of

allergic disease to 11 years. Pediatr Allergy Immunol. 2018;29(8):808-14.

3. López-López A, Castellote-Bargalló AI, Campoy-Folgoso C, Rivero-Urgell M, Tormo-Carnicé R,

Infante-Pina D, López-Sabater MC. The influence of dietary palmitic acid triacylglyceride position

on the fatty acid, calcium and magnesium contents of at term newborn faeces. Early Hum Dev.

2001;65 Suppl:S83-94.

4. Innis SM. Dietary triacylglycerol structure and its role in infant nutrition. Adv Nutr. 2011;2(3):275-83.

5. Nowacki J, Lee HC, Lien R, Cheng SW, Li ST, Yao M, Northington R, Jan I, Mutungi G. Stool fatty

acid soaps, stool consistency and gastrointestinal tolerance in term infants fed infant formulas

containing high sn-2 palmitate with or without oligofructose: a double-blind, randomized clinical

trial. Nutr J. 2014;13:105.

6. Yao M, Lien EL, Capeding MR, Fitzgerald M, Ramanujam K, Yuhas R, Northington R, Lebumfacil J,

Wang L, De-Russo PA. Effects of term infant formulas containing high sn-2 palmitate with and

without oligofructose on stool composition, stool characteristics, and bifidogenicity. J Pediatr

Gastroenterol Nutr. 2014;59(4):440-8.

7. Litmanovitz I, Bar-Yoseph F, Lifshitz Y, Davidson K, Eliakim A, Regev RH, Nemet D. Reduced

crying in term infants fed high beta-palmitate formula: a double-blind randomized clinical trial.

BMC Pediatr. 2014;14:152.

8. Mazzocchi A, D’Oria V, De Cosmi V, Bettocchi S, Milani GP, Silano M, Agostoni C. The Role of Lipids

in Human Milk and Infant Formulae. Nutrients. 2018;10(5):567.

9. Girardet JP, Rivero M, Orbegozo J, David T, Boulanger S, Moisson de Vaux A, Johnston S. Marin V.

Efficacité sur la croissance et tolerance d’une préparation pour nourrissons à base de protéines de

riz hydrolysées. Archives de Pédiatrie 20(3):323–8.

10. Reche M, Pascual C, Fiandor A, Polanco I, Rivero-Urgell M, Chifre R, Johnston S, Martín-Esteban M.

The effect of a partially hydrolysed formula based on rice protein in the treatment of infants with

cow’s milk protein allergy. Pediatr Allergy Immunol. 2010;21(4 Pt 1):577-85.

11. Nieto-Garcia A, Navas-López V, Espin B, Mazon A, Salhi H, Salamoura D, Kalach N, de Castellar-

Sansó R, Lemoine A. Hydrolyzed rice protein versus extensively hydrolyzed protein formulas in

growth and tolerance acquisition of infants with cow’s milk protein allergy: THE GRITO STUDY.

JPGN 2023; 76 (Sup 1): 961.

12. Pedrosa M, Pascual CY, Larco JI, Esteban MM. Palatability of hydrolysates and Other substitution

formulas for cow’s milk-allergic children: a comparative study of taste, smell, and texture evaluated

by healthy volunteers. J Investig Allergol Clin Immunol. 2006;16(6):351-6. PMID: 17153882.

13. Vandenplas Y, Broekaert I, Domellöf M, Indrio F, Lapillonne A, Pienar C, et al. An ESPGHAN position

paper on the diagnosis, management and prevention of cow’s milk allergy. J Pediatr Gastroenterol

Nutr. 2024; 78(2): 386-413.